688428 诺诚健华
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.448-6.352-8.562-13.432-1.482
总资产报酬率 ROA (%)-0.321-4.560-6.235-9.993-1.080
投入资产回报率 ROIC (%)-0.364-5.559-8.147-11.931-1.152

边际利润分析
销售毛利率 (%)89.51286.28582.61077.07193.704
营业利润率 (%)-4.223-44.683-88.168-142.820-2.058
息税前利润/营业总收入 (%)-10.478-54.124-96.557-115.510-20.041
净利润/营业总收入 (%)-4.872-44.862-87.420-142.904-6.393

收益指标分析
经营活动净收益/利润总额(%)286.010100.21599.186107.25526.887
价值变动净收益/利润总额(%)-84.1905.1587.512-0.977222.724
营业外收支净额/利润总额(%)-0.9870.341-1.0790.059-6.656

偿债能力分析
流动比率 (X)7.6607.4534.2104.49820.265
速动比率 (X)7.5457.3624.1534.46620.234
资产负债率 (%)28.25128.29227.61425.99023.683
带息债务/全部投入资本 (%)11.53911.821-3.009-3.389-1.829
股东权益/带息债务 (%)704.886685.486-3,145.418-2,821.776-4,429.447
股东权益/负债合计 (%)253.401252.683260.938283.003319.157
利息保障倍数 (X)1.6645.82710.349-4.2171.107

营运能力分析
应收账款周转天数 (天)91.457111.87198.51449.8207.839
存货周转天数 (天)250.279279.113258.45794.44532.336